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Abstract 
Objectives: Missing data due to study dropout is common in weight loss trials and several 
statistical methods exist to account for it. The aim of this study was to identify methods in the 
literature and to compare the effects of methods of analysis using simulated data sets. 
Methods: Literature was obtained for a 1-y period to identify analytical methods used in 
reporting weight loss trials. A comparison of methods with large or small between-group weight 
loss, and missing data that was, or was not, missing randomly was conducted in simulated data 
sets based on previous research. 
Results: Twenty-seven studies, some with multiple analyses, were retrieved. Complete case 
analysis (n ¼ 17), last observation carried forward (n ¼ 6), baseline carried forward (n ¼ 4), 
maximum likelihood (n ¼ 6), and multiple imputation (n ¼ 2) were the common methods of 
accounting for missing data. When comparing methods on simulated data, all demonstrated a 
significant effect when the between-group weight loss was large (P < 0.001, interaction term) 
regardless of whether the data was missing completely at random. When the weight loss 
interaction was small, the method used for analysis gave considerably different results with 
mixed models (P ¼ 0.180) and multiple imputations (P ¼ 0.125) closest to the full data model (P 
¼ 0.033). 
Conclusion: The simulation analysis showed that when data were not missing at random, 
treatment effects were small, and the amount of missing data was substantial, the analysis 
method had an effect on the significance of the outcome. Careful attention must be paid when 
analyzing or appraising studies with missing data and small effects to ensure appropriate 





Missing data in weight loss intervention trials is common, generally resulting when 
participants drop out of the study. This is referred to as a monotonic pattern of missing data  [1], 
where the participant remains in the study until a certain point after which all data are missing. 
Data also may be missing arbitrarily when participants miss an assessment, or when there is a 
mechanical or operator failure with equipment or procedures. 
 
Available statistical methods for dealing with missing data include the following: 
 Complete case analysis: Data from only the subset of participants with a measurement at 
every time point are analyzed.  
 Single imputation methods: Last observation carried forward (LOCF) and baseline 
carried forward (BCF) were a single value for each participant (the last observation 
observed or the baseline measurement) is used to replace the missing values for that 
participant.  
 Maximum likelihood (ML): Identifies population parameters most likely to produce the 
sample data  [2,3]. In this analysis, a form of maximum likelihood is used in the linear 
mixed model  [4] which uses the available data at each time point allowing for the use of 
partial datasets.  
 Multiple imputation (MI): This method involves three steps:  
1) several data sets are generated where the missing values are imputed by random 
draws from a plausible distribution,  
2) the individual data sets are analyzed using standard methods to determine the 
parameters of interest, and  
3) the parameter estimates from the individual analyses are combined accounting for 
both the individual sample variance and the extra variance introduced by the 
missing data  [5]. 
 
Statistical models used include general linear or linear mixed model for repeated 
measures.  
Missing data falls into one of three patterns  [1]. Missing completely at random (MCAR) 
refers to missing data that is unrelated to the study outcome or intervention. In data that is 
missing at random (MAR), the missing data pattern depends on some observed characteristic 
(e.g., those who have not lost weight at the first follow-up may be more likely to drop out than 
those who have lost weight). Missing not at random (MNAR) occurs when the missing data 
(missingness) depends on an unobserved characteristic. For example, if those who have not lost 
weight drop out of the study before any follow-up weight was recorded, then the data is 
dependent on the amount of weight loss even though this is not measured. It is most tenable that 
the mechanism of attrition in weight loss trials is MAR or MNAR. A recent systematic review, 
for example, showed that several characteristics predicted drop out in weight loss studies  [6] 
with five of six studies that investigated initial treatment effectiveness reporting an increased 
dropout rate in those who had lower initial weight loss. In this contribution, we review the types 
of methods used in the weight loss literature and compare the effects of MCAR and “not 






To obtain a sample of studies from which to extract representative sample sizes and 
dropout rates in weight loss trials, a PubMed search was conducted (November 2010). The 
primary search term was weight loss diet and limits were imposed to select only studies in the 
previous year, which were randomized controlled trials in adult humans published in English. 
Trials were included if the weight data analysis was reported and presented and the intervention 
was dietary related (not pharmaceutical). 
From the retrieved studies and data from existing trials  [7–9] an analysis of two 
simulated data sets was conducted. The simulations were developed to represent a weight loss 
trial conducted over a 1-y period with a rapid weight loss in the first 3 mo, followed by a slower 
weight loss over the rest of the trial. Starting weights, SDs, and the correlation structures were 
obtained from data from our research group  [7–9]. Weight loss at each time point (baseline, 3 
mo, and 12 mo) was estimated using data from the completer analysis in a previously published 
paper  [10]. This group of researchers showed an effect of a high-protein diet over 12 mo and 
demonstrated a significant difference in weight loss at 3 and 12 mo between the treatment and 
control groups using t tests adjusted for multiple comparisons (Bonferroni adjustment, P < 
0.017). A second data set was simulated that demonstrated a smaller between-group interaction, 
but still showed a significant between-group difference in weight change between base-line and 
12 mo-1.89 kg (95% confidence interval [CI], -3.62 to -0.16; P = 0.033). 
Data were simulated from a multivariate normal distribution with a fixed correlation 
structure. Weights and SDs for the full case analyses are presented in Tables  1 to  4, the 
correlation matrix based on our previous research  [9] was (1, 0.987, 0.954, 0.987, 1, 0.967, 
0.954, 0.967, 1) for the treatment group (n = 53) and (1, 0.966, 0.933, 0.966, 1, 0.962, 0.933, 
0.962, 1) for the controls (n = 53). To generate the missing data, participants were randomly 
removed in approximately equal numbers at each post-baseline time point to generate a reduced 
data set (MCAR) with a monotone pattern of missingness. For comparison, a data set in which 
the participants dropping out were randomly removed only from the half of the population that 
lost the least amount of weight at 3 mo, meaning those who were “failing,” were overrepresented 
in the dropouts, this data set contained both MAR and MNAR cases (not MCAR). 
The full, complete case, LOCF, and BCF data sets were analyzed using a repeated 
measures analysis of variance in the general linear model (SPSS V19.0, IBM Corporation, 
Armonk NY). ML estimation was conducted using the linear mixed model on all available data 
(using SPSS version 19.0 or SAS V9.2, Cary NC). MI (PROC MI using SAS v9.2) was followed 
by analysis using the linear mixed model, the default of five imputations was used for all models  
[1] with an additional comparison with 20 imputations for the lower weight loss models. The F 
statistics were combined using the combchi macro [3] for combining P-values from imputations  
[11]. An ad hoc sensitivity analysis  [1] was performed on the not MCAR data set imputations 
with the small difference. The purpose of the sensitivity analysis is to demonstrate what 
procedures are available when it was suspected that the MAR assumptions are violated. Constant 
values were obtained to add to the multiply imputed values by using a small (0.2, treatment) and 





Twenty-seven studies were used to determine a representative sample size and dropout 
rate  [9,10,13–37].  Table 5 provides summary statistics for the baseline sample sizes and 
completers, the dropout rates, and the methods used to account for missing data and analysis. 
The simulations were based on the identified sample sizes with rounding to whole participant 
numbers. One hundred and six participants were simulated separately in equal sample sizes of 53 
in the treatment and control groups. The two dropout rates were 24% (approximate average) and 
approximately double this (47%) for the high dropout. 
Tables  1 to  4 show the results of the different methods of analysis on the simulated data 
sets. In all analyses, the interaction effect was significant when the time X group interaction 
(treatment) effect was large and there was an average amount of missing data ( Tables 2 and 4).   
Tables 1 and 3 show the results of the analyses of the data sets with large amounts of 






























Treatment                           
  Baseline  88.00  1.68  53    89.52  2.43  28    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53 
  3 mo  80.68  1.69  53    82.03  2.35  28    81.89  1.94  40    82.66  1.66  53    81.10  1.66  53    84.05  1.66  53 
  12 mo  77.69  1.74  53    78.67  2.45  28    78.67  2.45  28    80.89  1.72  53    77.02  1.86  53    82.27  1.75  53 
  Change  10.31        10.85        9.33        7.11        10.98        5.73     
Control                                               
  Baseline  87.20  1.75  53    88.78  2.53  28    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53 
  3 mo  81.46  1.73  53    82.72  2.35  28    82.45  1.98  39    83.19  1.67  53    81.93  1.79  53    84.00  1.67  53 
  12 mo  78.78  1.93  53    79.73  2.66  28    79.73  2.66  28    81.61  1.82  53    78.23  2.01  53    82.42  1.83  53 
  Change  8.42        9.05        7.47        5.59        8.97        4.78     
Type 3 fixed effects                         
  Time  0.000        0.000        0.000        0.000        0.000 * 0.000
†
    0.000     
  Group  0.884        0.923        0.879        0.950        0.867  0.994     0.922     
































Treatment                           
  Baseline  88.00  1.68  53    87.43  1.95  40    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53 
  3 mo  79.18  1.69  53    77.67  1.97  40    76.94  1.77  46    79.46  1.87  53    78.14  1.69  53    81.26  1.76  53 
  12 mo  76.19  1.74  53    75.49  1.96  40    75.49  1.96  40    77.81  1.90  53    76.22  1.71  53    78.94  1.89  53 
  Change  11.81        11.94        12.51        10.19        11.78        9.06     
Control                                               
  Baseline  87.20  1.75  53    86.61  2.03  40    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53 
  3 mo  82.96  1.73  53    84.29  2.03  40    83.50  1.81  46    85.09  1.78  53    82.96  1.73  53    84.15  1.76  53 
  12 mo  80.28  1.93  53    80.33  2.19  40    80.33  2.19  40    82.10  1.92  53    80.28  1.93  53    81.75  1.89  53 
  Change  6.92        6.28        6.87        5.10        6.92        5.45     
Type 3 fixed effects                         
  Time  0.000        0.000        0.000        0.000        0.010       0.000     
  Group  0.149        0.213        0.147        0.232        0.157        0.512     
  Interaction 0.000        0.000        0.000        0.000        0.000        0.000     
BCF, baseline carried forward; LOCF, last observation carried forward; MCAR, missing completely at random 
Table 3: Weights at study time points for all analysis methods, 47% missing data, small‐effect not MCAR 


























Treatment                           
  Baseline  88.00  1.68  53    89.12  2.09  28    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53 
  3 mo  80.68  1.69  53    80.44  2.08  28    80.22  1.86  40    82.03  1.73  53    80.08  0.96  53    83.42  1.72  53 
  12 mo  77.69  1.74  53    77.55  2.21  28    77.55  2.21  28    80.51  1.81  53    76.99  1.01  53    81.89  1.82  53 
  Change  10.31        11.57        10.45        7.49        11.01        6.11     
Control                                          
  Baseline  87.20  1.75  53    89.38  2.22  28    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53 
  3 mo  81.46  1.73  53    81.29  2.21  28    83.19  1.81  39    82.37  1.68  53    80.66  1.02  53    82.93  1.73  53 
  12 mo  78.78  1.93  53    78.36  2.56  28    78.37  2.56  28    80.82  1.85  53    77.41  1.16  53    81.38  1.90  53 
  Change  8.42        11.02        8.83        6.38        9.79        5.82     
Type 3 fixed effects                           
  Time  0.000        0.000        0.000        0.000        0.000*  0.000
†
    0.000     
  Group  0.884        0.837        0.993        0.983        0.932  0.934     0.807     
































Treatment                           
  Baseline  88.00  1.68  53    87.75  1.88  40    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53    88.00  1.68  53 
  3 mo  79.18  1.69  53    78.45  1.84  40    79.03  1.80  46    80.17  1.72  53    78.95  1.66  53    80.98  1.77  53 
  12 mo  76.19  1.74  53    75.79  1.89  40    75.79  1.89  40    78.17  1.80  53    76.66  1.75  53    78.98  1.86  53 
  Change  11.81        11.96        12.21        9.83        11.34        9.02     
Control                                              
  Baseline  87.20  1.75  53    87.96  1.97  40    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53    87.20  1.75  53 
  3 mo  82.96  1.73  53    82.91  1.93  40    83.05  1.79  46    83.78  1.71  53    82.56  1.75  53    83.39  1.72  53 
  12 mo  80.28  1.93  53    80.11  2.20  40    80.11  2.20  40    81.06  1.90  53    79.62  1.98  53    81.27  1.91  53 
  Change  6.92        7.85        7.09        6.14        7.58        5.93     
Type 3 fixed effects                                             
  Time  0.000       0.000        0.000        0.000        0.000      0.000     
  Group  0.149       0.276        0.397        0.489        0.434        0.599     
  Interaction 0.000       0.000        0.000        0.000        0.000        0.000     
BCF, baseline carried forward; LOCF, last observation carried forward; MCAR, missing completely at random 
 
None of the other methods produce a significant interaction at a level of <0.05; however, 
the mixed model, MI (with 20 imputations), and complete case analysis give similar P-values to 
the full data set analysis and approach significance. When the dropout rate depends on the initial 
weight loss and the percentage dropout is large, none of the commonly used methods produce a 
result similar to that given by the full data set ( Table 3). An ad hoc sensitivity analysis was 
conducted by calculating effect sizes based on the SD of the change in weight between week 12 
and baseline in the completers (SD = 3.73), a constant value of 0.746 kg (small effect) was added 
to the imputed values in the 20 multiply imputed treatment groups a value of 1.865 kg (medium 
effect) in the control groups. This sensitivity analysis produced a significant interaction term (P = 
0.012,  Table 3,  Fig. 1). 
 






























Complete case analysis, LOCF, and BCF continue to be used to analyze missing data in 
weight loss trials despite substantial literature identifying the limitations and biases of these 
methods. Complete case analysis is only valid if the data are MCAR  [38] and even in this case 
the analysis is inefficient as the sample size is reduced. Although LOCF and BCF are 
computationally straight forward, they are not developed using any statistical procedures, and as 
such there is no guarantee they are valid even when assuming MCAR  [39,40]. Both have been 
shown in some circumstances to demonstrate elevated type I error rates dispelling the belief that 
this procedure is always conservative  [41,42]. In weight loss trials, some recidivism is common 
in longer studies. Carrying forward a value at an early time point where the weight loss is 
greatest may introduce bias  [41]. ML and MI are the currently preferred methods for dealing 
with missing data in the general context  [3,40,43,44] when the data are MCAR or MAR. 
When commonly used methods were compared on simulated data sets to demonstrate the 
differences obtained with different amounts and types of missing data, all methods gave 
statistically significant results when the interaction effect was large, regardless of whether the 
amount of missing data was average or high. The methods gave vastly different results when the 
missingness pattern depended on the initial weight loss and when the amount of missing data 
was large (47%). Despite the significant results with all methods when there was a large effect, 
examination of the weight estimates and changes at the different time points ( Tables 2 and 4) 
clearly demonstrates differences between the methods with the recommended methods (ML and 
MI) giving results much closer to the actual values. 
Computationally, the mixed model and MI should produce equivalent results when the 
same variables are used in both models  [45] however the mixed model performs poorly when 
there are large amounts of missing data and the data are not MCAR. Multiple imputations with 
the default setting of 5 imputations also performed poorly results better matched the true values 
when 20 imputations were used. This supports the literature when a higher number of 
imputations is recommended with large amounts of missing data  [45]. When the amount of 
missing data is large and effect sizes small it is important to consider a range of different 







A previous analysis  [46] examined the performance of different methods for handling 
missing data in weight loss trials, however, this research based the analysis on 12 studies using a 
variety of supplements, meal replacements, and pharmaceutical treatments as opposed to dietary 
interventions. These researchers  [46] reviewed the literature from an earlier period (2000–2006) 
and reported the different methods employed in weight loss studies, which included a 
pharmaceutical arm. They reported that 59% of studies used LOCF, 11% ML, 2% MI, and 16% 
a completers-only analysis. Our later analysis of the literature suggests that inappropriate 
methods are still frequently used; however, the complete case analysis was the most common 
method in the studies we reviewed. This previous research  [46] concluded that the mixed model 
and imputation were the best approaches, with MI performing better when missing data rates 
were greater (30%–38%) because mixed models were more susceptible to inflated type 1 error 
rates. Our results are consistent with this conclusion; however, we caution that the result is 
dependent on the effect size, as well as the amount of missing data. Despite finding a mean 
dropout rate of 26.3%, the analysis in this previous work  [46], the comparison of analysis 
methods involved 12 data sets with an average of only 15% of missing data. The present study 
investigated small data sets with a higher dropout rate, as this is our experience of nutritionally 
based clinical weight loss trials  [9]. Additionally 2 of the 27 retrieved studies reported dropout 
rates >47% and a recent systematic review reports dropouts ranging from 10% to 80% in weight 
loss studies  [6]. 
Almost a decade ago, Gadbury et al  [47] discussed the use of both ML and MI as 
preferred methods to analyze data in obesity research. However, these authors only examined a 
single weight loss scenario in which there was a 7 kg between-group treatment difference with 
missing data ranging from 20% to 50%. In the current analysis, smaller differences are 
considered and the choice of method has a substantial effect on the conclusions drawn in this 
case. 
ML and MI are recommended for use when the data are MAR  [46,47]. More recently, 
missing data analysis has focused on models for MNAR data  [2,39]. Two classes of MNAR 
models, selection models and pattern mixture models, are most commonly described in recent 
literature  [2,39,40]. Because these models are computationally complex, a simpler approach (ad 
hoc sensitivity method) is used in this study. This method is easier to describe and still 
demonstrates the concept of testing the sensitivity of the models to their implicit assumptions  
[1]. The ad hoc analysis showed the effect of assuming that those who dropped out lost less 
weight than those who remained by adding weight to each imputed value. This brought the 
interac-tion effect closer to the real value for the full data set. This is not surprising, as in this 
case the missing data were constructed to be not MCAR by preferentially removing participants 
who had lost the least amount of weight, thus making this adjustment return the estimates closer 
to the real value. In a real weight loss trial situation, this information is not usually available. 
Given that there is generally always missing data in weight loss studies, it is not possible 
to “prove” the validity of the assumptions, therefore simulations such as the ones presented in 
this study are necessary. Missing data that was generated to be MCAR or not MCAR was 
employed to highlight the effects that these assumptions may have on outcomes of analyses. 
These assumptions are not possible to test in real clinical studies, although it is likely that data in 
weight loss trials are MAR or MNAR. When data are not MCAR, it is important to consider 
various approaches and include reasonable variations from the assumptions to draw sensible 
conclusions. 
Although more complicated to employ than the conventional complete case or single 
imputation methods, the inclusion of mixed model and imputation procedures in the more 
commonly used statistical packages such as SPSS (with MI from version 17.0, IBM Corporation, 
Armonk NY) and STATA (with MI from version 11, College Station, TX), in addition to their 
longer-standing inclusion in SAS (Cary, NC), makes these procedures more available to the 
nutrition practitioner. Linear mixed models allow more flexibility than standard repeated 
measures analysis, including the inclusion of time-varying covariates, fixed and random effects, 
and different covariance structures that are useful for studies with more than two time points and 





In the case of a moderate amount of missing data and a substantial effect size, all   
methods of analysis will give significant results. The mixed model or MI are the preferred 
methods because they give the most accurate estimates. When the amount of missing data is 
considerable, sample sizes are modest or results are of borderline significance. Several 
techniques should be employed and the results compared as a sensitivity analysis to ensure that 
results are valid and plausible. In agreement with previous research, our results do not support 
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